Who
Whittemore Tingley
Chief Medical Officer
Company insider
Files Form 4 as: Chief Medical Officer, Tenaya Therapeutics.
In numbers
- Trades disclosed
- 53
- Buys
- 0
- Sells
- 10
- Bought
- $0
- Sold
- $118K
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 15 Feb 2022
- Last trade
- 10 Sep 2026
- Last filed
- 11 Sep 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 10 Sep 2026filed 11 Sep 2026 | TNYA Tenaya TherapeuticsBiotechnology | SEC FORM 4 Code A | —49,000 at $0.00 | filing |
| 10 Sep 2026filed 11 Sep 2026 | TNYA Tenaya Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —293,000 at $0.00 | filing |
| 10 Sep 2026filed 11 Sep 2026 | TNYA Tenaya Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —293,000 at $0.00 | filing |
| 10 Sep 2026filed 11 Sep 2026 | TNYA Tenaya TherapeuticsBiotechnology | SEC FORM 4 Code A | —49,000 at $0.00 | filing |
| 17 Aug 2026filed 17 Aug 2026 | TNYA Tenaya TherapeuticsBiotechnology | SEC FORM 4 Sold | $1,1621,637 at $0.7098 | filing |
| 17 Aug 2026filed 17 Aug 2026 | TNYA Tenaya TherapeuticsBiotechnology | SEC FORM 4 Sold | $1,1621,637 at $0.7098 | filing |
| 17 Aug 2026filed 17 Aug 2026 | TNYA Tenaya TherapeuticsBiotechnology | SEC FORM 4 Sold | $1,3281,871 at $0.7098 | filing |
| 17 Aug 2026filed 17 Aug 2026 | TNYA Tenaya TherapeuticsBiotechnology | SEC FORM 4 Sold | $1,6182,279 at $0.7098 | filing |
| 17 Aug 2026filed 17 Aug 2026 | TNYA Tenaya TherapeuticsBiotechnology | SEC FORM 4 Sold | $1,1621,637 at $0.71 | filing |
| 17 Aug 2026filed 17 Aug 2026 | TNYA Tenaya TherapeuticsBiotechnology | SEC FORM 4 Sold | $1,1621,637 at $0.71 | filing |
| 17 Aug 2026filed 17 Aug 2026 | TNYA Tenaya TherapeuticsBiotechnology | SEC FORM 4 Sold | $1,3281,871 at $0.71 | filing |
| 17 Aug 2026filed 17 Aug 2026 | TNYA Tenaya TherapeuticsBiotechnology | SEC FORM 4 Sold | $1,6182,279 at $0.71 | filing |
| 18 May 2026filed 19 May 2026 | TNYA Tenaya TherapeuticsBiotechnology | SEC FORM 4 Sold | $2,4773,121 at $0.7936 | filing |
| 18 May 2026filed 19 May 2026 | TNYA Tenaya TherapeuticsBiotechnology | SEC FORM 4 Sold | $2,4663,121 at $0.79 | filing |
| 17 Feb 2026filed 17 Feb 2026 | TNYA Tenaya TherapeuticsBiotechnology | SEC FORM 4 Sold | $1,0561,642 at $0.6432 | filing |
| 17 Feb 2026filed 17 Feb 2026 | TNYA Tenaya TherapeuticsBiotechnology | SEC FORM 4 Sold | $1,0561,642 at $0.6432 | filing |
| 17 Feb 2026filed 17 Feb 2026 | TNYA Tenaya TherapeuticsBiotechnology | SEC FORM 4 Sold | $1,2061,876 at $0.6431 | filing |
| 17 Feb 2026filed 17 Feb 2026 | TNYA Tenaya TherapeuticsBiotechnology | SEC FORM 4 Sold | $1,0511,642 at $0.64 | filing |
| 17 Feb 2026filed 17 Feb 2026 | TNYA Tenaya TherapeuticsBiotechnology | SEC FORM 4 Sold | $1,0511,642 at $0.64 | filing |
| 17 Feb 2026filed 17 Feb 2026 | TNYA Tenaya TherapeuticsBiotechnology | SEC FORM 4 Sold | $1,2011,876 at $0.64 | filing |
News
Tenaya Therapeutics (NASDAQ:TNYA) versus Sutro Biopharma (NASDAQ:STRO) Head-To-Head ComparisonTNYA · themarketsdaily.com · 20 Oct 2026
0 headlines in the last 90 days name Whittemore Tingley; 1 article from the last 14 days about the 1 company they traded most, at most three about any one of them.